Andrew Sunol

Andrew Sunol is an associate in Goodwin’s Private Equity group in New York. He represents large-cap and middle-market private equity sponsors and their portfolio companies across a broad range of corporate transactions, including leveraged buyouts, control and structured investments, add-on acquisitions, industry roll-ups, convertible instruments, carve-outs, co-investments, divestitures and exit transactions.

Andrew has also advised clients on take-private transactions, debt and equity financings, cross-border investments, founder liquidity and structuring matters, restructurings and reorganizations, and distressed sales (including as part of Chapter 11 proceedings), as well as general corporate, shareholder, governance and strategic matters.

Select representative matters include:

Private Equity Investments / Buyouts:

• Funds associated with TA Associates on its strategic investments in:
  • PureSpectrum, Inc., a leading information services network serving the insights and market research industry
  • OneSource Virtual, Inc., a leading provider of HR and payments services for the Workday ecosystem
• Funds associated with JMI Equity on its strategic investment in EdSights, an AI-powered student voice platform
• Funds associated with Thomas H. Lee Partners on its $1.6 billion majority controlling investment in Standish Management, a leading independent provider of fund administration services for private equity, venture capital and real estate managers*
• Funds associated with Kingswood Capital Management on its buyout of Safran Passenger Innovations, a leading global provider of in-flight entertainment and connectivity solutions for airlines and aircraft manufacturers worldwide
• Funds associated with B Capital on its Series C strategic growth investment in CompanyCam, a leading job site productivity and AI platform
• The majority exit by the founders and certain search fund investors of a leading medical EHR solution provider to a mid-market private equity firm
• Funds associated with Mercury Capital on its roll-up of Australian recycling operators, including its investment in Re.Group and acquisition of assets of Polytrade*
• Funds associated with Affinity Equity Partners on the ~$350 million sale of its portfolio company MedicalDirector, a leading Australian provider of medical practice management software, to Telstra Health*
• Funds associated with PAG on its secured $150 million convertible investment into ASX-listed Regional Express Airlines (ASX: REX) during COVID-19*
• Founders of Skyline Landscaping on their exit to a portfolio company controlled by Mercury Capital as part of Mercury's landscaping service provider roll-up*
• Funds associated with Next Capital on its:
  • Initial investment in, and sale of, Funlab, a leading Australian entertainment business, to funds associated with TPG Capital for ~$250 million*
  • Co-investment into Eptec Group, a specialist defense and engineering contractor, and subsequent add-ons and related investments*

Strategic Acquisitions & Add-Ons:

• Funds associated with Level Equity and its portfolio company Healthy Roster on its acquisition of Sway Medical, a pioneer in mobile balance and cognitive assessment technology
• Funds associated with Arlington Capital Partners on add-on acquisition for its portfolio company which operates in the defense industry
• Funds associated with American Securities and its portfolio company Foundation Building Materials (sold to Lowe's Companies Inc. (NYSE: LOW) for $8.8 billion in 2025)* on its:
  • Acquisition of substantially all assets of the Marjam Supply Company group*
  • Divestment of a significant stake in Foundation Building Materials to Clayton, Dubilier & Rice*
• A publicly listed company on the purchase of certain entertainment and water park assets

Other Notable Transactions:

• Dun & Bradstreet on its $7.7 billion take-private sale to funds associated with Clearlake Capital Group*
• Steward Health Care System LLC, the largest private, physician-owned for-profit healthcare network in the United States with over $9 billion in funded debt obligations, in connection with numerous time-sensitive hospital and related asset sales as part of its Chapter 11 restructuring*
• Eli Lilly and Company on its acquisition of certain assets from Lacerta as a result of an assignment for the benefit of creditors proceeding*
• Ontario Teachers' Pension Fund on an employee stock repurchase for one of its portfolio companies*

*Denotes experience prior to joining Goodwin.

Prior to joining Goodwin, Andrew worked as an associate in the New York office of Weil, Gotshal & Manges LLP where he advised large-cap sponsors, listed public companies and a range of private and distressed companies on a broad range of corporate transactions.

Before moving to the United States, Andrew worked as an associate of a Band 2 ranked Chambers and Partners Private Equity team at two leading independent law firms in Sydney, Australia. Andrew has also previously served as an Officer in the Royal Australian Navy.

• New Colombo Plan Scholar